A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase

Molecular Therapy. Nucleic Acids
Kelly M Podetz-PedersenR Scott McIvor

Abstract

The Sleeping Beauty (SB) transposon system has been shown to enable long-term gene expression by integrating new sequences into host cell chromosomes. We found that the recently reported SB100x hyperactive transposase conferred a surprisingly high level of long-term expression after hydrodynamic delivery of luciferase-encoding reporter transposons in the mouse. We conducted dose-ranging studies to determine the effect of varying the amount of SB100x transposase-encoding plasmid (pCMV-SB100x) at a set dose of luciferase transposon and of varying the amount of transposon-encoding DNA at a set dose of pCMV-SB100x in hydrodynamically injected mice. Animals were immunosuppressed using cyclophosphamide in order to prevent an antiluciferase immune response. At a set dose of transposon DNA (25 µg), we observed a broad range of pCMV-SB100x doses (0.1-2.5 µg) conferring optimal levels of long-term expression (>10(11) photons/second/cm(2)). At a fixed dose of 0.5 μg of pCMV-SB100x, maximal long-term luciferase expression (>10(10) photons/second/cm(2)) was achieved at a transposon dose of 5-125 μg. We also found that in the linear range of transposon doses (100 ng), co-delivering the CMV-SB100x sequence on the same plasmid was less effecti...Continue Reading

References

Jun 27, 2002·Journal of Molecular Biology·Zongbin CuiPerry B Hackett
Jul 5, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aron M GeurtsPerry B Hackett
Oct 8, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jacob Giehm MikkelsenMark A Kay
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hatem ZayedZoltán Ivics
Sep 10, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·James BausBradley S Fletcher
Dec 17, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paul R ScoreR Scott McIvor
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Perry B Hackett
Apr 19, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Andrew WilberXin Wang
Dec 26, 2008·Briefings in Functional Genomics & Proteomics·Jun NiStephen C Ekker
Jul 16, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jason B BellPerry B Hackett
Jul 24, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Zsuzsanna IzsvákZoltán Ivics
Apr 5, 2011·Human Molecular Genetics·Elena L AronovichPerry B Hackett
Jul 19, 2011·The Journal of Gene Medicine·Kendra A HylandR Scott McIvor
Aug 6, 2014·Human Gene Therapy·Kelly M Podetz-PedersenR Scott McIvor

❮ Previous
Next ❯

Citations

Jun 24, 2021·JHEP Reports : Innovation in Hepatology·Sheila MaestroGloria Gonzalez-Aseguinolaza
Dec 16, 2021·Science Translational Medicine·Xiao-Jing ZhangHongliang Li

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.